Beating back cancer, cell by cell

February 21, 2014
In 2005, Providence Cancer Center spun off a biotechnology startup to develop and commercialize several promising cancer vaccines and to take advantage of federal grant money available for innovative science and technology research.

Today, UbiVac is charging ahead with several vaccines based on the principle that the best way to fight cancer might be to energize the body’s own immune system.

Read more in the Portland Business Journal.